RESHAPE LIFESCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.168 USD | +0.18% |
|
-0.77% | -32.72% |
| Apr. 12 | North American Morning Briefing : Big Banks Kick -2- | DJ |
| Apr. 01 | Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024 |
Presenter SpeechDaniel Kontoh-Boateng (Attendees)Good afternoon and thank you for joining the ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
Calendar
2024-05-19
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.168
USD
Average target price
1
USD
Spread / Average Target
+495.24%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -32.72% | 3.94M | |
| +11.73% | 226B | |
| +9.53% | 188B | |
| +14.63% | 137B | |
| +27.47% | 108B | |
| -0.04% | 63.19B | |
| +13.73% | 52.26B | |
| +4.86% | 51B | |
| +7.72% | 43.89B | |
| +7.86% | 38.07B |
- Stock Market
- Equities
- RSLS Stock
- News ReShape Lifesciences Inc.
- Transcript : ReShape Lifesciences Inc., Q2 2021 Earnings Call, Aug 16, 2021